149 related articles for article (PubMed ID: 2433905)
1. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
Jackson RC; Leopold WR; Ross DA
Adv Enzyme Regul; 1986; 25():125-39. PubMed ID: 2433905
[TBL] [Abstract][Full Text] [Related]
2. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Agarwal RP
Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
[No Abstract] [Full Text] [Related]
3. 2'-Chloropentostatin: discovery, fermentation and biological activity.
Tunac JB; Underhill M
J Antibiot (Tokyo); 1985 Oct; 38(10):1344-9. PubMed ID: 3934118
[TBL] [Abstract][Full Text] [Related]
4. Adechlorin, a new adenosine deaminase inhibitor containing chlorine production, isolation and properties.
Omura S; Imamura N; Kuga H; Ishikawa H; Yamazaki Y; Okano K; Kimura K; Takahashi Y; Tanaka H
J Antibiot (Tokyo); 1985 Aug; 38(8):1008-15. PubMed ID: 3840153
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
6. Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.
Deibel MR; Coleman MS; Hutton JJ
Biochem Med; 1981 Jun; 25(3):288-97. PubMed ID: 6973972
[No Abstract] [Full Text] [Related]
7. Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
Plunkett W
Ann N Y Acad Sci; 1985; 451():150-9. PubMed ID: 3907452
[No Abstract] [Full Text] [Related]
8. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Shewach DS; Plunkett W
Biochem Pharmacol; 1982 Jun; 31(11):2103-9. PubMed ID: 6180754
[No Abstract] [Full Text] [Related]
9. Adenosine deaminase inhibitors. Synthesis and biological evaluation of (+/-)-3,6,7,8-tetrahydro-3-[(2-hydroxyethoxy)methyl]imidazo[4,5-d] [1,3]diazepin-8-ol and some selected C-5 homologues of pentostatin.
Showalter HD; Putt SR; Borondy PE; Shillis JL
J Med Chem; 1983 Oct; 26(10):1478-82. PubMed ID: 6604819
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
Svendsen KR; Overgaard-Hansen K; Frederiksen S
Cancer Chemother Pharmacol; 1988; 21(1):35-9. PubMed ID: 3257721
[TBL] [Abstract][Full Text] [Related]
12. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP
Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622
[TBL] [Abstract][Full Text] [Related]
13. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
14. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biochemical properties of 8-amino-6-fluoro-9-beta-D-ribofuranosyl-9H-purine.
Secrist JA; Bennett LL; Allan PW; Rose LM; Chang CH; Montgomery JA
J Med Chem; 1986 Oct; 29(10):2069-74. PubMed ID: 3489838
[TBL] [Abstract][Full Text] [Related]
16. Isolation of mutant adenosine deaminase by coformycin affinity chromatography.
Danton MJ; Coleman MS
Anal Biochem; 1986 Nov; 159(1):233-9. PubMed ID: 3492941
[TBL] [Abstract][Full Text] [Related]
17. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
Ballow M; Pantschenko AG
Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
[No Abstract] [Full Text] [Related]
19. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
Russell NH; Hoffbrand AV; Bellingham AJ
Leuk Res; 1986; 10(3):325-9. PubMed ID: 3081767
[TBL] [Abstract][Full Text] [Related]
20. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
